This improvement in contrast to hemoglobin and pre-albumin which did not show significant changes—likely due to their sensitivity to inflammation, shorter half-lives, and tendency to be influenced by factors beyond nutrition alone, as noted in previous studies [48], highlights the complexity of interpreting biochemical responses to nutritional interventions in cancer care settings. The gene discussed is ALB; the disease is cancer.